Rate My Professor Woojin Kim

Associate Professor Woojin Kim serves in the Neuroscience Research Theme, School of Medical Sciences, Faculty of Medicine and Health at the University of Sydney. He is affiliated with the Brain and Mind Centre and contributes to research on neurodegenerative disorders. His investigations center on lipid metabolism dysregulation, ATP-binding cassette (ABC) transporters, and biomarker development for diseases including Parkinson's disease, Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Kim's studies explore how alterations in lipid pathways, such as sphingomyelin and cholesterol homeostasis in glial cells, contribute to disease pathology. He examines ABC transporters like ABCA7 and ABCA5 in brain lipid transport and their implications for neurodegeneration. Additionally, his work addresses alpha-synuclein aggregation, endogenous retroviruses, and biofluid changes predictive of neurodegeneration.

Kim has authored numerous peer-reviewed articles in prestigious journals, often as corresponding author. Notable publications include 'Lipid pathway dysfunction is prevalent in patients with Parkinson's disease' (Brain, 2022), demonstrating widespread lipid alterations in PD patients; 'Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis' (Brain, 2022), identifying proteomic signatures; 'Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts' (PNAS, 2019), revealing patient-specific fibril strains; 'Predicting neurodegeneration from sleep related biofluid changes' (Neurobiology of Disease, 2024); 'ATP-binding cassette transporters and neurodegenerative diseases' (Essays in Biochemistry, 2021); 'Sex-specific lipid dysregulation in the Abca7 knockout mouse brain' (Brain Communications, 2022); and 'Systemic dysregulation of apolipoproteins in amyotrophic lateral sclerosis serum' (FEBS Open Bio, 2024). His research has accumulated over 5,000 citations on Scopus, reflecting substantial impact. Kim participates in initiatives like the CogSleep Centre of Research Excellence, supporting seed funding for sleep-neurodegeneration projects.